Credit score: Novo Nordisk Novo Nordisk’s $6 billion funding at this plant in Denmark is one in every of a number of for peptide-based weight-loss medicine. Novo Nordisk is spending $6 billion in Kalundborg, Denmark, to develop the manufacturing of lively pharmaceutical components (APIs), together with peptides utilized in weight-loss and antidiabetic medicine. The Danish…